Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

Articles published in
Ann Intern Med
    September 2021
  1. FOJO AT, Schnure M, Kasaie P, Dowdy DW, et al
    What Will It Take to End HIV in the United States? : A Comprehensive, Local-Level Modeling Study.
    Ann Intern Med. 2021 Sep 21. doi: 10.7326/M21-1501.
    >> Share

  2. LINAS BP
    Ending HIV in the United States Will Require a Substantial Financial Commitment.
    Ann Intern Med. 2021 Sep 21. doi: 10.7326/M21-3607.
    >> Share

    August 2021
  3. CHURCHYARD G, Cardenas V, Chihota V, Mngadi K, et al
    Annual Tuberculosis Preventive Therapy for Persons With HIV Infection : A Randomized Trial.
    Ann Intern Med. 2021 Aug 24. doi: 10.7326/M20-7577.
    >> Share

  4. BERHANU RH, Jacobson KR
    Tuberculosis Preventive Therapy for People With HIV Infection in High Tuberculosis Burden Settings: How Much Is Enough?
    Ann Intern Med. 2021 Aug 24. doi: 10.7326/M21-3170.
    >> Share

    July 2021
  5. EDWARDS JK, Cole SR, Breger TL, Rudolph JE, et al
    Mortality Among Persons Entering HIV Care Compared With the General U.S. Population : An Observational Study.
    Ann Intern Med. 2021 Jul 6. doi: 10.7326/M21-0065.
    >> Share

  6. GLESBY MJ, Gulick RM
    HIV: Closing the Mortality Gap.
    Ann Intern Med. 2021 Jul 6. doi: 10.7326/M21-2586.
    >> Share

    April 2021
  7. KUHN A, Maatman T
    Annals Graphic Medicine - Should I PrEP? Barriers to HIV-Related Preventive Care Faced by Black MSM.
    Ann Intern Med. 2021 Apr 13. doi: 10.7326/G20-0086.
    >> Share

  8. TITANJI B, Hernandez-Romieu AC, Adelman MW
    Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy.
    Ann Intern Med. 2021;174:580-581.
    >> Share

  9. DEL AMO J, Polo R, Moreno S, Diaz A, et al
    Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy.
    Ann Intern Med. 2021;174:581-582.
    >> Share

    March 2021
  10. SURIAL B, Mugglin C, Calmy A, Cavassini M, et al
    Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV : A Cohort Study.
    Ann Intern Med. 2021 Mar 16. doi: 10.7326/M20-4853.
    >> Share

  11. CHAMMARTIN F, Lodi S, Logan R, Ryom L, et al
    Risk for Non-AIDS-Defining and AIDS-Defining Cancer of Early Versus Delayed Initiation of Antiretroviral Therapy : A Multinational Prospective Cohort Study.
    Ann Intern Med. 2021 Mar 16. doi: 10.7326/M20-5226.
    >> Share


  12. Summary for Patients: Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV.
    Ann Intern Med. 2021 Mar 16. doi: 10.7326/P21-0002.
    >> Share

    December 2020
  13. ROBBINS C, Martocci S
    Timing of Prenatal Care Initiation in the Health Resources and Services Administration Health Center Program in 2017.
    Ann Intern Med. 2020;173.
    >> Share

    November 2020
  14. ARD KL, Walensky RP
    Payments for Preexposure Prophylaxis in the United States: Too Much for Too Few.
    Ann Intern Med. 2020;173:844-845.
    >> Share

    September 2020
  15. DAS M, Ting J, Shreay S, Bush S, et al
    Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis.
    Ann Intern Med. 2020;173:506-507.
    >> Share

  16. WALENSKY RP, Horn T, McCann NC, Freedberg KA, et al
    Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis.
    Ann Intern Med. 2020;173:507-508.
    >> Share

  17. FURUKAWA NW, Zhu W, Huang YA, Shrestha RK, et al
    National Trends in Drug Payments for HIV Preexposure Prophylaxis in the United States, 2014 to 2018 : A Retrospective Cohort Study.
    Ann Intern Med. 2020 Sep 8. doi: 10.7326/M20-0786.
    >> Share

    July 2020
  18. SHARIFI H, Karamouzian M, Khorrami Z, Khalili M, et al
    Estimation of Coronavirus Disease 2019 Burden and Potential for International Dissemination of Infection From Iran.
    Ann Intern Med. 2020;173:73-74.
    >> Share

  19. BRAINARD D, McCallister S
    Tenofovir Alafenamide for HIV Preexposure Prophylaxis.
    Ann Intern Med. 2020;173:77-78.
    >> Share

  20. KRAKOWER DS, Daskalakis DC, Feinberg J, Marcus JL, et al
    Tenofovir Alafenamide for HIV Preexposure Prophylaxis.
    Ann Intern Med. 2020;173:78.
    >> Share

    June 2020
  21. DEL AMO J, Polo R, Moreno S, Diaz A, et al
    Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy: A Cohort Study.
    Ann Intern Med. 2020 Jun 26. doi: 10.7326/M20-3689.
    >> Share

  22. TWAHIRWA RWEMA JO, Diouf D, Phaswana-Mafuya N, Rusatira JC, et al
    COVID-19 Across Africa: Epidemiologic Heterogeneity and Necessity of Contextually Relevant Transmission Models and Intervention Strategies.
    Ann Intern Med. 2020 Jun 18. doi: 10.7326/M20-2628.
    >> Share

  23. ROSS JE
    Resident Response During Pandemic: This Is Our Time.
    Ann Intern Med. 2020;172:824-825.
    >> Share

    May 2020
  24. WEISER J, Tie Y, Beer L, Pearson WS, et al
    Receipt of Prevention Services and Testing for Sexually Transmitted Diseases Among HIV-Positive Men Who Have Sex With Men, United States.
    Ann Intern Med. 2020 May 5. pii: 2765673. doi: 10.7326/M19-4051.
    >> Share

  25. DEL RIO C, Armstrong WS
    How Much Are We Willing to Pay for Preexposure Prophylaxis in the United States?
    Ann Intern Med. 2020;172:623-624.
    >> Share

    March 2020
  26. WALENSKY RP, Horn T, McCann NC, Freedberg KA, et al
    Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis: A Cost-Effectiveness Analysis.
    Ann Intern Med. 2020 Mar 10. pii: 2762726. doi: 10.7326/M19-3478.
    >> Share

    February 2020
  27. LEVY Y, Lelievre JD, Assoumou L, Aznar E, et al
    Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection: A Randomized Trial.
    Ann Intern Med. 2020 Feb 11. pii: 2760879. doi: 10.7326/M19-2133.
    >> Share

    January 2020
  28. KRAKOWER DS, Daskalakis DC, Feinberg J, Marcus JL, et al
    Tenofovir Alafenamide for HIV Preexposure Prophylaxis: What Can We DISCOVER About Its True Value?
    Ann Intern Med. 2020 Jan 14. pii: 2758848. doi: 10.7326/M19-3337.
    >> Share

    October 2019
  29. SINGH M
    Guideline: USPSTF recommends preexposure prophylaxis with antiretroviral therapy for persons at high risk for HIV.
    Ann Intern Med. 2019;171:JC38.
    >> Share

    April 2019
  30. SIMONI JM, Nance RM, Whitney BM, Saag MS, et al
    HIV Viral Suppression Trends.
    Ann Intern Med. 2019;170:582-583.
    >> Share

  31. KLEIN P, Mandsager P, Dempsey A, Hauck H, et al
    HIV Viral Suppression Trends.
    Ann Intern Med. 2019;170:582.
    >> Share

  32. DUGDALE CM, Ciaranello AL, Bekker LG, Stern ME, et al
    Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential: A Modeling Study.
    Ann Intern Med. 2019 Apr 2. pii: 2729814. doi: 10.7326/M18-3358.
    >> Share

    January 2019

  33. Correction: Mechanisms That Contribute to a Profound Reduction of the HIV-1 Reservoir After Allogeneic Stem Cell Transplant.
    Ann Intern Med. 2019;170:80.
    >> Share

    October 2018
  34. SALGADO M, Kwon M, Galvez C, Badiola J, et al
    Mechanisms That Contribute to a Profound Reduction of the HIV-1 Reservoir After Allogeneic Stem Cell Transplant.
    Ann Intern Med. 2018 Oct 16. pii: 2707334. doi: 10.7326/M18-0759.
    >> Share

  35. D'AQUILA R
    Learning About "Known Unknowns" and "Unknown Unknowns" to Cure HIV.
    Ann Intern Med. 2018 Oct 16. pii: 2707999. doi: 10.7326/M18-2822.
    >> Share

    August 2018
  36. MARSTON HD, Dieffenbach CW, Fauci AS
    Ending the HIV Epidemic in the United States: Closing the Implementation Gaps.
    Ann Intern Med. 2018 Aug 21. pii: 2698044. doi: 10.7326/M18-1944.
    >> Share

  37. NANCE RM, Delaney JAC, Simoni JM, Wilson IB, et al
    HIV Viral Suppression Trends Over Time Among HIV-Infected Patients Receiving Care in the United States, 1997 to 2015: A Cohort Study.
    Ann Intern Med. 2018 Aug 21. pii: 2697568. doi: 10.7326/M17-2242.
    >> Share

    June 2018
  38. CHANG JL, Tsai AC, Musinguzi N, Haberer JE, et al
    Depression and Suicidal Ideation Among HIV-Infected Adults Receiving Efavirenz Versus Nevirapine in Uganda: A Prospective Cohort Study.
    Ann Intern Med. 2018 Jun 26. pii: 2686096. doi: 10.7326/M17-2252.
    >> Share

  39. PARK LS, Tate JP, Sigel K, Brown ST, et al
    Association of Viral Suppression With Lower AIDS-Defining and Non-AIDS-Defining Cancer Incidence in HIV-Infected Veterans: A Prospective Cohort Study.
    Ann Intern Med. 2018 Jun 12. pii: 2684480. doi: 10.7326/M16-2094.
    >> Share

    May 2018
  40. SHIELS MS, Islam JY, Rosenberg PS, Hall HI, et al
    Projected Cancer Incidence Rates and Burden of Incident Cancer Cases in HIV-Infected Adults in the United States Through 2030.
    Ann Intern Med. 2018 May 8. pii: 2680725. doi: 10.7326/M17-2499.
    >> Share

    April 2018
  41. DURHAM DP, Fitzpatrick MC, Ndeffo-Mbah ML, Parpia AS, et al
    Evaluating Vaccination Strategies for Zika Virus in the Americas.
    Ann Intern Med. 2018 Apr 3. pii: 2677349. doi: 10.7326/M17-0641.
    >> Share

    March 2018
  42. SINGH S, Song R, Johnson AS, McCray E, et al
    HIV Incidence, HIV Prevalence, and Undiagnosed HIV Infections in Men Who Have Sex With Men, United States.
    Ann Intern Med. 2018 Mar 20. pii: 2675979. doi: 10.7326/M17-2082.
    >> Share

    February 2018
  43. ZAR FA
    Guideline: Recommendations are provided for antiretroviral therapies in pregnant women with HIV.
    Ann Intern Med. 2018;168:JC14.
    >> Share

    December 2017
  44. WEISER J, Perez A, Bradley H, King H, et al
    Low Prevalence of Hepatitis B Vaccination Among Patients Receiving Medical Care for HIV Infection in the United States, 2009 to 2012.
    Ann Intern Med. 2017 Dec 26. pii: 2667091. doi: 10.7326/M17-1689.
    >> Share

    November 2017
  45. ABARA WE, Qaseem A, Schillie S, McMahon BJ, et al
    Hepatitis B Vaccination, Screening, and Linkage to Care: Best Practice Advice From the American College of Physicians and the Centers for Disease Control and Prevention.
    Ann Intern Med. 2017 Nov 21. doi: 10.7326/M17-1106.
    >> Share

  46. KREBS E, Enns B, Evans E, Urada D, et al
    Cost-Effectiveness of Publicly Funded Treatment of Opioid Use Disorder in California.
    Ann Intern Med. 2017 Nov 21. doi: 10.7326/M17-0611.
    >> Share

  47. PAULES CI, Eisinger RW, Marston HD, Fauci AS, et al
    What Recent History Has Taught Us About Responding to Emerging Infectious Disease Threats.
    Ann Intern Med. 2017 Nov 14. doi: 10.7326/M17-2496.
    >> Share

  48. MALEBRANCHE DJ
    Beautiful.
    Ann Intern Med. 2017;167:679-680.
    >> Share

    August 2017
  49. KATTAKUZHY S, Gross C, Emmanuel B, Teferi G, et al
    Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers: A Nonrandomized Clinical Trial.
    Ann Intern Med. 2017 Aug 8. doi: 10.7326/M17-0118.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016